Midgard Science
NY

New York Genome Center Sequencing Core Facility

New York, NY, United States nygenome.org

From their website, Nov 2026

Work here? Claim this listing

About

The New York Genome Center is an independent, nonprofit academic research institution and multi-institutional hub for collaborative genomic research. It serves academic, biotechnology, pharmaceutical, clinical, and other research organizations, and is headquartered in New York, New York.

Services

  • Research sequencing

    Provides scalable, high-throughput research sequencing services, including whole genome sequencing, RNA sequencing, single-cell sequencing, and long-read sequencing.

  • Clinical targeted variant testing

    Independently confirms findings from single-gene, panel, exome, and/or genome sequencing performed on a research basis, and can confirm known familial mutations.

  • Panel sequencing (PS)

    Offers panel sequencing test options for patients with undiagnosed diseases, carrier screening, and pharmacogenomic testing.

  • Standard genome sequencing (GS) and rapid genome sequencing (rGS)

    Provides clinical genome sequencing tests offered as trio testing, with samples also accepted from affected or unaffected relatives when appropriate.

  • Whole genome and transcriptome sequencing for oncology

    Sequences the tumor genome, matched normal specimen, and tumor transcriptome for oncology cases where broader mutational profiling is informative.

  • Small Multiply Aggregated Sequence Homologies (SMASH)

    Provides low-coverage whole-genome sequencing based detection of copy number variants, including CNVs as small as 10 kb.

  • Technology development

    Develops and translates genomics and single-cell innovations into practical tools and methodologies, including novel genomic technologies.

  • Computational biology / bioinformatics

    Develops tools and processing pipelines and analyzes human genomics data in collaboration with sequencing and research groups.

  • Biology, genomics, and technology collaborative research

    Advances and deploys novel genomic technologies such as molecular diagnostic testing, liquid biopsy, single-cell analysis, CRISPR gene editing, spatial transcriptomics, and laboratory computational methods.

  • Short read whole genome sequencing

    Performs short read whole genome sequencing for genomic research.

  • Transcriptomic and total RNA sequencing

    Carries out transcriptomic and total RNA sequencing for research samples.

  • Lane sequencing of prepared library pools

    Provides lane sequencing for prepared library pools.

  • Single cell and single nuclei sequencing

    Supports single cell and single nuclei sequencing workflows.

  • Long read sequencing

    Provides long read sequencing for research applications.

  • Computational analysis of genomic and transcriptomic data

    Analyzes genomic and transcriptomic data using computational methods.

  • Population-level statistical analyses

    Performs population-level statistical analyses for genomic research projects.

  • Integration of diverse data sets

    Integrates diverse genomic and transcriptomic data sets.

  • Technology development for genomics and single-cell methods

    Develops and evaluates genomic and single-cell technologies and workflows.

  • Bioinformatics method and pipeline development

    Develops tools and processing pipelines for human genomics analysis.

Turnaround
2-3 weeks · 4-6 weeks · 6-8 weeks
What to send
5ml of blood drawn in an EDTA tube · Saliva specimen collected in an Oragene Dx collection kit · DNA extracted in a CLIA-certified laboratory · Samples shipped overnight via FedEx

Capabilities

Assays and studies
Short read whole genome sequencing · Transcriptomic sequencing · Total RNA sequencing · Lane sequencing of prepared library pools · Single cell sequencing · Single nuclei sequencing · Long read sequencing · Targeted variant testing · Panel sequencing · Standard genome sequencing · Rapid genome sequencing · Whole genome and transcriptome sequencing
6 moreCopy number variant detection · Low-coverage whole genome sequencing · Lane sequencing · Pathogen identification methods · Somatic variant prioritization · Mitochondrial genome analysis
Scale and capacity
170,000 SF research facility · 30,000 SF of sequencing lab space · 50,000 whole genome equivalents
Therapeutic areas
Neurological diseases · Cancer · Neurodegenerative diseases · Neuropsychiatric diseases · ALS

Instruments and platforms

  • Next-generation sequencing

Modalities and species

Modalities
Gene editing
Species and models
Human · Affected and unaffected relatives · Proband · Biological parents · Tumor · Matched normal specimen · Human genomics · Mendelian diseases · Complex diseases

Certifications

As the company states them, with the certificate or registry record where there is one.

  • CLIASelf-reported

    Scope: clinical lab at the facility

Industries served

  • Academic
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Industry
  • Private foundations
  • Large consortia

Company

Type
Core facility
Quality
CLIA/CLEP (clinical lab) · CLIA-certified laboratory (DNA extraction source for targeted variant testing)

Locations

Based in
New York, NY, United States
Sites
New York, USA
Serves
New York, beyond New York

Contacts

Public records

Research Resource Identifier (CoreMarketplace)
RRID:SCR_029065 source

Similar labs

Work here? Claim this listing